Healthcare provider profile · identity verified

Kerry Hildreth, MD

Geriatric Medicine · AURORA, CO · NPI 1982825543

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	365	108
Levothyroxine Sodium	Levothyroxine Sodium	277	76
Amlodipine Besylate	Amlodipine Besylate	241	80
Lisinopril	Lisinopril	225	66
Losartan Potassium	Losartan Potassium	193	56
Rosuvastatin Calcium	Rosuvastatin Calcium	179	54
Alendronate Sodium	Alendronate Sodium	126	42
Hydrochlorothiazide	Hydrochlorothiazide	110	34
Omeprazole	Omeprazole	105	31
Metformin Hcl	Metformin Hcl	99	31
Zolpidem Tartrate	Zolpidem Tartrate	93	22
Albuterol Sulfate Hfa	Albuterol Sulfate	91	35
Gabapentin	Gabapentin	84	32
Trazodone Hcl	Trazodone Hcl	80	27
Tamsulosin Hcl	Tamsulosin Hcl	78	26
Eliquis	Apixaban	77	14
Metoprolol Succinate	Metoprolol Succinate	75	24
Simvastatin	Simvastatin	71	24
Sertraline Hcl	Sertraline Hcl	68	21
Potassium Chloride	Potassium Chloride	60	20
Pantoprazole Sodium	Pantoprazole Sodium	52	16
Escitalopram Oxalate	Escitalopram Oxalate	45	16
Fluoxetine Hcl	Fluoxetine Hcl	45	13
Furosemide	Furosemide	42	16
Metformin Hcl Er	Metformin Hcl	40	13
Duloxetine Hcl	Duloxetine Hcl	38	11
Jardiance	Empagliflozin	38	suppressed
Allopurinol	Allopurinol	37	suppressed
Bupropion Xl	Bupropion Hcl	36	12
Citalopram Hbr	Citalopram Hydrobromide	36	14
Ozempic	Semaglutide	36	suppressed
Meloxicam	Meloxicam	35	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	12
Metoprolol Tartrate	Metoprolol Tartrate	34	13
Alprazolam	Alprazolam	33	11
Estradiol	Estradiol	32	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Valacyclovir	Valacyclovir Hcl	31	11
Diclofenac Sodium	Diclofenac Sodium	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	suppressed
Acyclovir	Acyclovir	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Fluticasone Propionate	Fluticasone Propionate	19	suppressed
Lorazepam	Lorazepam	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	17	suppressed
Glipizide	Glipizide	17	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Carvedilol	Carvedilol	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Finasteride	Finasteride	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Baclofen	Baclofen	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Vilazodone Hcl	Vilazodone Hcl	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Flunisolide	Flunisolide	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error